Literature DB >> 33555497

A novel homozygous nonsense mutation in the CA2 gene (c.368G>A, p.W123X) linked to carbonic anhydrase II deficiency syndrome in a Chinese family.

Yan Yang1,2, Nie Tang1,2, Ying Zhu1,2, Lei Zhang1,2, Xu Cao1,2, Limei Liu1,2, Wei Xia1,2, Pengqiu Li1,2, Yi Yang3,4.   

Abstract

BACKGROUND: Carbonic anhydrase II deficiency syndrome is an autosomal recessive osteopetrosis with renal tubular acidosis and cerebral calcifications. We tried to detect the causative mutation for carbonic anhydrase II deficiency syndrome in a five-generation Chinese family.
MATERIALS AND METHODS: Genomic DNA was extracted from whole blood of the proband, his grandmother, parents, aunt, uncle and sister. The exomes were sequenced by whole exon sequencing followed by genetic analysis and Sanger sequencing validation. Then, physical and chemical properties studies and structure analysis were performed on mutated protein. Finally, Minigene model of vector plasmids for wild type and mutant type was constructed and transfected into human embryonic kidney 293T cells to further explore the expression change of CA2 transcript and protein after mutation.
RESULTS: Sequencing and genetic analysis have revealed the homozygous nonsense mutation of CA2 gene (c.368G > A, p.W123X) in the exon 4 of chromosome 8 of the proband, while it was not found in his grandmother, parents, aunt, uncle and sister. Furthermore, Sanger sequencing in the proband and his parents validated the mutation. Properties and structure of mutated CA2 proteins changed after mutation, especially in change of protein modification and hindrance of zinc ions binding, which may lead to decreased protein expression level of CA2.
CONCLUSIONS: We found a new homozygous nonsense mutation in CA2 gene (c.368G > A, p.W123X), which may be valuable in the early diagnosis and therapy of carbonic anhydrase II deficiency syndrome.

Entities:  

Keywords:  CA2; Carbonic anhydrase II deficiency syndrome; Homozygous nonsense mutation; Human embryonic kidney 293T cells; Minigene model; Whole exome sequencing

Year:  2021        PMID: 33555497     DOI: 10.1007/s11011-021-00677-9

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  12 in total

Review 1.  Splicing in action: assessing disease causing sequence changes.

Authors:  D Baralle; M Baralle
Journal:  J Med Genet       Date:  2005-10       Impact factor: 6.318

2.  Solvent-mediated proton transfer in catalysis by carbonic anhydrase.

Authors:  David N Silverman; Robert McKenna
Journal:  Acc Chem Res       Date:  2007-06-06       Impact factor: 22.384

Review 3.  Structure and mechanism of carbonic anhydrase.

Authors:  S Lindskog
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

4.  Paralysis Episodes in Carbonic Anhydrase II Deficiency.

Authors:  Alia Al-Ibrahim; Mosa Al-Harbi; Sulaiman Al-Musallam
Journal:  Saudi J Kidney Dis Transpl       Date:  2003 Jan-Mar

5.  Mice carrying a CAR-2 null allele lack carbonic anhydrase II immunohistochemically and show vascular calcification.

Authors:  S S Spicer; S E Lewis; R E Tashian; B A Schulte
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

6.  Carbonic anhydrase II deficiency syndrome (osteopetrosis with renal tubular acidosis and brain calcification): novel mutations in CA2 identified by direct sequencing expand the opportunity for genotype-phenotype correlation.

Authors:  Gul N Shah; Giuseppe Bonapace; Peiyi Y Hu; Pietro Strisciuglio; William S Sly
Journal:  Hum Mutat       Date:  2004-09       Impact factor: 4.878

7.  Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification.

Authors:  W S Sly; D Hewett-Emmett; M P Whyte; Y S Yu; R E Tashian
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

8.  A practical approach to genetic hypokalemia.

Authors:  Shih-Hua Lin; Sung-Sen Yang; Tom Chau
Journal:  Electrolyte Blood Press       Date:  2010-06-30

9.  A Calsequestrin-1 Mutation Associated with a Skeletal Muscle Disease Alters Sarcoplasmic Ca2+ Release.

Authors:  Maria Cristina D'Adamo; Luigi Sforna; Sergio Visentin; Alessandro Grottesi; Llenio Servettini; Luca Guglielmi; Lara Macchioni; Simona Saredi; Maurizio Curcio; Chiara De Nuccio; Sonia Hasan; Lanfranco Corazzi; Fabio Franciolini; Marina Mora; Luigi Catacuzzeno; Mauro Pessia
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

10.  CPVT-associated cardiac ryanodine receptor mutation G357S with reduced penetrance impairs Ca2+ release termination and diminishes protein expression.

Authors:  Yingjie Liu; Jinhong Wei; Siobhan M Wong King Yuen; Bo Sun; Yijun Tang; Ruiwu Wang; Filip Van Petegem; S R Wayne Chen
Journal:  PLoS One       Date:  2017-09-29       Impact factor: 3.240

View more
  1 in total

1.  Bis-pharmacophore of cinnamaldehyde-clubbed thiosemicarbazones as potent carbonic anhydrase-II inhibitors.

Authors:  Asif Rasool; Zahra Batool; Majid Khan; Sobia Ahsan Halim; Zahid Shafiq; Ahmed Temirak; Mohamed A Salem; Tarik E Ali; Ajmal Khan; Ahmed Al-Harrasi
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.